Australian trader faces prison term for market manipulation

The Australian Securities and Investments Commission (ASIC) has announced that a Melbourne man is charged with multiple counts of market manipulation.

On 2 July 2021, Mr Gabriel Govinda of Melbourne, Victoria, appeared at a filing hearing in the Melbourne Magistrates’ Court faced with 23 charges of market manipulation and 19 charges of illegal dissemination of information relating to the manipulation.

The allegations relate to trading in 20 different securities quoted on the ASX between September 2014 and July 2015.

The Commonwealth Director of Public Prosecutions is prosecuting the matter after a referral from ASIC. The matter is next in court on 3 September 2021 for Committal Mention.

The alleged contraventions are:

  • 23 charges of 1041B of the Corporations Act 2001, (false or misleading appearance of active trading in, or with respect to the market or price for, securities); and
  • 19 charges of 1041D of the Corporations Act 2001 (Dissemination of information about illegal transactions).

The trader faces a maximum penalty for each charge of 10 years’ imprisonment or a fine of up to $765,000, or both.

Posted on

21,772 Replies to “Australian trader faces prison term for market manipulation”

  1. It s worth noting that I will talk about impact at both a personal and an organizational level, partly because the personal is political at so many academic institutions, and since we wouldn t have these repositories at all if it weren t for our people purchasing cialis online

  2. Make sure you bring your camera. clomid cycle In addition to the constitutive expression of hepatic CYP1A2, the activity of CYP1A2 can be regulated by a range of extrinsic and intrinsic factors, such as induced by cigarette smoking and heavy coffee consumption, inhibited by oral contraceptives 50 , and coregulated by other liver-enriched transcription factors 51.

  3. We have previously observed that FYN, one of the Src family kinases, is important for growth and survival of our MCF 7 derived tamoxifen resistant cell lines 41, and that the broad spectrum Src family kinase inhibitor PP2 exerted preferential growth inhibition of the tamoxifen resistant MCF 7 breast cancer cell lines compared to the parental cells 41 normal dose of lasix